Green William D, Gomez Amber, Plotkin Alec L, Pratt Brandon M, Merritt Emily F, Mullins Genevieve N, Kren Nancy P, Modliszewski Jennifer L, Zhabotynsky Vasyl, Woodcock Mark G, Green Jarred M, Cannon Gabrielle, Pipkin Matthew E, Dotti Gianpietro, Thaxton Jessica E, Pylayeva-Gupta Yuliya, Baldwin Albert S, Morris John P, Stanley Natalie, Milner J Justin
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Immunity. 2025 Jul 8;58(7):1725-1741.e9. doi: 10.1016/j.immuni.2025.04.030. Epub 2025 May 26.
Tumor-infiltrating lymphocytes (TILs) with a tissue-resident memory CD8 T cell (Trm) phenotype are associated with improved patient outcomes in solid malignancies. To define programs governing the formation of Trm-like TIL, we performed paired single-cell RNA sequencing and single-cell ATAC sequencing of T cell receptor (TCR)-matched CD8 T cells in models of infection and cancer. Enhancer-driven regulons assembled from multiomic profiling data revealed epigenetic and transcriptional programs regulating the formation of Trm-like TIL in relation to canonical exhausted and memory T cell states. The transcriptional regulator KLF2 repressed the formation of CD69CD103 Trm-like TIL and limited anti-tumor activity. Conversely, sustained expression of the transcription factor BATF enhanced formation of CD69CD103 TIL, contingent upon downregulation of KLF2. Transforming growth factor β (TGF-β) signaling and CD103 expression were necessary for Trm-like TIL formation, but BATF overexpression was sufficient to drive formation of CD69CD103 TIL in TGFBR2-silenced cells. These findings reveal mechanisms of Trm-like TIL differentiation and provide a framework for considering tissue residency in the context of CD8 T cell heterogeneity in the tumor microenvironment.
具有组织驻留记忆CD8 T细胞(Trm)表型的肿瘤浸润淋巴细胞(TILs)与实体恶性肿瘤患者预后改善相关。为了确定调控类Trm TIL形成的程序,我们在感染和癌症模型中对T细胞受体(TCR)匹配的CD8 T细胞进行了配对单细胞RNA测序和单细胞ATAC测序。从多组学分析数据组装的增强子驱动调控子揭示了与典型耗竭和记忆T细胞状态相关的调控类Trm TIL形成的表观遗传和转录程序。转录调节因子KLF2抑制CD69CD103类Trm TIL的形成并限制抗肿瘤活性。相反,转录因子BATF的持续表达增强了CD69CD103 TIL的形成,这取决于KLF2的下调。转化生长因子β(TGF-β)信号传导和CD103表达是类Trm TIL形成所必需的,但BATF过表达足以在TGFBR2沉默的细胞中驱动CD69CD103 TIL的形成。这些发现揭示了类Trm TIL分化的机制,并为在肿瘤微环境中CD8 T细胞异质性背景下考虑组织驻留提供了一个框架。